Cleveland Clinic Florida
Weston, Florida, 33331, United States
NCT Number: NCT02476448
This study evaluates 4 different methods to aid surgeons to visualize ureteral jets on cystoscopy.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Weston, Florida, 33331, United States
This study proposes to test and compare the surgeon's impression/confidence in identifying ureteral jets using 3 other methods in contrast to standard diagnostic cystoscopy: 1) cystoscopy with Dextrose 10% solution, 2) cystoscopy with phenazopyridine and 3) IV sodium fluorescein 4) standard cystoscopy with saline.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Used to distend the bladder for cystoscopic evaluation
Other names: Saline, NS
Administered orally preoperatively and assessed during cystoscopy
Other names: Pyridium, AZO
Used to distend the bladder for cystoscopic evaluation
Other names: D10
Administered intravenously and assessed during cystoscopy
Other names: Fluorescein, Fluorocyte
Time frame: 5 minutes
Surgeons will chose from a likert scales as either:
Time frame: 5 mins
A 4 point likert scale will be completed during the procedure to assess satisfaction as follows:
Time frame: 6 weeks
Medical records will be followed prospectively for 6 weeks to assess for incidence of urinary tract infections within different groups.
Cecilia Calvo
Other
Evaluation of Ureteral Jets on Cystoscopy: A Randomized Controlled Trial
Acronym: JET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.